Graphical abstract
Keywords: Pulmonary embolism, Transthoracic echocardiography, Thrombolysis
Highlights
-
•
PE is very rarely identified on TTE.
-
•
Saddle PE does not represent a higher-risk subset of PE.
-
•
Catheter-based therapies are becoming more commonplace in the management of acute PE.
Introduction
While transthoracic echocardiography (TTE) is not a first-line test in the diagnosis of acute pulmonary embolism (PE), indirect signs such as right ventricular (RV) dilatation and dysfunction may be a clue to the diagnosis and aid in risk stratification. Saddle PE, that is, one occurring at the bifurcation of the main pulmonary artery (PA), is very seldom detected via TTE; only a few case reports describe this finding.1,2 Acoustic windows often pose a limit to the visualization of the pulmonary trunk and bifurcation. Here we present a patient suspected to have acute coronary syndrome (ACS) diagnosed with saddle embolism by TTE.
Case Presentation
A 59-year-old man with a history of hypertension and chronic kidney disease stage II presented to the emergency department with a week of exertional dyspnea. Several days prior, the patient was evaluated by a primary care physician for similar symptoms and prescribed azithromycin for a presumptive diagnosis of bronchitis. As symptoms continued to worsen, they sought medical attention in the emergency department. On initial evaluation, heart rate was 76 beats per minute, blood pressure was 111/73 mm Hg, and oxygen saturation of 97% on room air. The physical examination was benign: the patient was in no apparent distress, breathing comfortably, and was not diaphoretic; there was no lower extremity tenderness or swelling. The patient did not have a history of venous thromboembolism, did not suffer recent trauma, and did not have an active or prior malignancy.
The electrocardiogram in triage demonstrated T-wave inversions in the precordial leads with S waves in lead I and Q waves along with T-wave inversions in lead III (Figure 1). Labs were significant for a troponin I of 0.14 ng/mL (normal, <0.08), brain natriuretic peptide of 534 pg/mL (normal, <100), and serum creatinine of 1.55 mg/dL (normal range, 0.7-1.3). Chest x-ray did not demonstrate pneumothorax, pleural effusion, or signs of parenchymal disease.
As the electrocardiogram demonstrated precordial T-wave inversions in this patient without active chest discomfort, a diagnosis of Wellen’s syndrome was made by emergency providers. The patient was therefore treated for a non-ST segment elevation myocardial infarction with aspirin, clopidogrel, and heparin. An echocardiogram was ordered by emergency physicians to define left ventricular (LV) systolic function, and cardiology was consulted to evaluate the patient for coronary angiography.
Prior to cardiology evaluation, the patient was admitted to a telemetry unit and a TTE was performed. On echocardiography, the right ventricle (RV) was dilated and hypokinetic with preserved LV systolic function. The RV base was measured at 5.1 cm (normal range, 2.5-4.1 cm), RV mid diameter was 4.0 cm (normal range, 1.9-3.5 cm), and proximal RV outflow tract measured 4.0 cm (normal range, 2.1-3.5 cm).3 The tricuspid annular plane systolic excursion (TAPSE) was 1.1 cm (abnormality threshold, <1.7 cm), and the tricuspid regurgitation maximum velocity was 4.0 m/sec (estimated RV systolic pressure = 72 mm Hg).3 A linear mobile echodensity consistent with thrombus was visualized at the bifurcation of the main PA (Figure 2, Video 1). Coronary angiography was therefore deferred, and a computed tomography (CT) pulmonary arteriogram was performed that demonstrated a dilated main PA (3.7 cm) and saddle PE in addition to extensive bilateral emboli involving all lobes and extending into the segmental and subsegmental vessels (Figure 3).
Due to persistent symptoms and significant clot burden, the patient underwent catheter-directed thrombolysis. Following pulmonary angiography, thrombolysis catheters were expanded in the bilateral PAs with tissue plasminogen activator infused at a rate of 1 mg per hour over 5 hours (Figure 4, Video 2). Postprocedure, the patient had an uneventful hospital course, described much improved dyspnea with ambulation, and was discharged on apixaban in 48 hours.
Discussion
We present a patient with an unprovoked, intermediate- to high-risk PE (imaging evidence of RV dysfunction and abnormal cardiac laboratory biomarkers) initially masquerading as a non-ST segment elevation myocardial infarction. A saddle PE was identified by TTE prior to confirmation by CT angiography. The electrocardiographic RV injury pattern with precordial T-wave inversions is a known mimic of ACS.4 However, patients with ACS are more likely to have T-wave inversions extending through leads V5-6 (absent in our patient), while patients with PE were more likely to have T-wave inversions in the inferior leads (present in lead III in our patient).4 The absence of tachycardia in our patient is interesting and may have dissuaded the initial pursuit of the diagnosis of acute PE. However, tachycardia is found in approximately 38% of cases of acute PE and the lower heart rate may have been suggestive of some degree of chronicity.5
Saddle PE is a rare finding on TTE, with few case reports published.1,2,6,7 The pulmonary trunk may be visualized in the parasternal short-axis view with the probe fanned cephalad.8 In this view, the pulmonic valve and PA and its branches are assessed in addition to proximal and distal RV outflow tract segments.8 The detection of thrombus in this view may be challenging due to poor acoustic windows. In our patient, increased clot echogenicity, at times associated with chronicity, may have aided visualization. Among patients too unstable for CT with suboptimal TTE findings to fully assess RV dilatation/dysfunction, visualization of PA thrombus may assist in the diagnosis of PE.
The subcostal short-axis of the basal RV provides similar information when the parasternal short-axis view is limited.8 A modified right parasternal view may allow for the visualization of the distal right PA branch. With the patient in a steep left lateral decubitus position, the right PA is examined with the transducer at 30° to 45° to the chest wall at the second intercostal space immediately to the right of the sternum.9 The left PA branch is challenging to visualize both by TTE and transesophageal echocardiography as it is shielded by the left main stem bronchus.10 However, as the left PA dilates, it may be more readily seen as the window becomes more available around the acoustic limitations.
Echocardiographic signs are highly specific while lacking sensitivity for the diagnosis of acute PE among patients without underlying cardiopulmonary disease.11 In a large meta-analysis, “right heart strain” (defined as RV dysfunction, RV strain, an abnormal right heart, or cor pulmonale) was 83% specific but only 53% sensitive for the diagnosis of acute PE.11 McConnell’s sign (RV free wall akinesis with apical sparing) is commonly associated with acute PE and is 97% specific while only 22% sensitive for the diagnosis.11,12 Following its initial description, subsequent studies noted this finding to be less specific than initially thought.12 The “60/60 sign,” defined as a tricuspid regurgitation jet gradient of <60 mm Hg and a pulmonary acceleration time of >60 msec, is more objective and reproducible than McConnell’s sign and carries a pooled specificity of 84%.11 The sensitivity of TTE among more critical patients with higher pretest probability may be improved.
Beyond its use in the diagnosis of acute PE, echocardiographic findings carry prognostic value. Tricuspid annular plane systolic excursion, a well-known and relatively simple measure, along with several additional markers of RV systolic function, have been shown to inconsistently predict PE-related mortality.12 More recently, the LV outflow tract velocity-time integral, a stroke volume surrogate, was demonstrated to predict short-term outcomes even among initially normotensive patients.13 Thrombus in transit, due to its propensity to cause immediate hemodynamic instability, carries a high mortality rate, particularly without therapy.12 Accordingly, echocardiographic findings may inform on prognosis and assist in selecting patients for interventional therapies.
Saddle PE accounts for <5% of all PE cases. Before widespread use of CT angiography, this finding was often postmortem and therefore synonymous with a severe, hemodynamically significant presentation. However, several studies have dispelled this assertion, demonstrating similar clinical outcomes among those with and without saddle PE.14,15 Saddle emboli may be less flow limiting, with distal clot burden having more impact on RV function.14
With the evolution of catheter-based therapies, the management of PE has seen a revolution over the past decade. Often coupled with mechanisms allowing for thrombus fragmentation, catheter-directed thrombolysis allows for the delivery of tissue plasminogen activator directly into the clot at a fraction of the usual systemic dose.16 Observational studies demonstrate improved surrogate end points among patients with intermediate- and high-risk PE.17 As our patient with intermediate- to high-risk PE had persistent symptoms despite systemic anticoagulation, catheter-directed thrombolysis was selected as the next management step, leading to a significant subjective improvement. With several randomized control trials underway, we hope to see appropriate use criteria better defined for interventional therapies in acute PE.
Conclusion
The echocardiographic assessment of RV function factors into risk stratification among patients with acute PE. However, saddle PE is rarely detected via TTE and only a few case reports describe this finding. While historically thought to be a harbinger of a more severe presentation, recent studies prove saddle emboli are associated with similar short-term outcomes as nonsaddle PE.
Consent Statement
The authors declare that since this was a non-interventional, retrospective, observational study utilizing de-identified data, informed consent was not required from the patient under an IRB exemption status.
Ethics Statement
The authors declare that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans.
Funding Sources
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Conflict of Interest
The authors report no conflict of interest.
Footnotes
Supplementary data to this article can be found online at https://doi.org/10.1016/j.case.2023.11.006.
Supplementary Data
References
- 1.Kanjanauthai S., Couture L.A., Fissha M., Gentry M., Sharma G.K. Saddle pulmonary embolism visualized by transthoracic echocardiography. J Am Coll Cardiol. 2010;56:e21. doi: 10.1016/j.jacc.2009.10.097. [DOI] [PubMed] [Google Scholar]
- 2.Secko M., Legome E., Rinnert S. Saddle embolism diagnosed by point-of-care transthoracic echocardiography before computed tomography angiogram of the chest. Am J Emerg Med. 2016;34:2467.e1–2467.e2. doi: 10.1016/j.ajem.2016.06.037. [DOI] [PubMed] [Google Scholar]
- 3.Lang R.M., Badano L.P., Mor-Avi V., Afilalo J., Armstrong A., Ernande L., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1–39.e14. doi: 10.1016/j.echo.2014.10.003. [DOI] [PubMed] [Google Scholar]
- 4.Kosuge M., Ebina T., Hibi K., Tsukahara K., Iwahashi N., Umemura S., et al. Differences in negative T waves between acute pulmonary embolism and acute coronary syndrome. Circ J. 2014;78:483–489. doi: 10.1253/circj.cj-13-1064. [DOI] [PubMed] [Google Scholar]
- 5.Shopp J.D., Stewart L.K., Emmett T.W., Kline J.A. Findings from 12-lead electrocardiography that predict circulatory shock from pulmonary embolism: systematic review and meta-analysis. Acad Emerg Med. 2015;22:1127–1137. doi: 10.1111/acem.12769. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Letourneau M.M., Wilczynski S., Rao S., Osman A. Two-for-One saddles: a case of mobile double pulmonary embolism. CASE (Phila) 2018;2:66–68. doi: 10.1016/j.case.2017.09.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Pandompatam G., Qaseem M. A 55-year-old man with progressive shortness of breath. Chest. 2022;162:e321–e323. doi: 10.1016/j.chest.2021.12.676. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Rudski L.G., Lai W.W., Afilalo J., Hua L., Handschumacher M.D., Chandrasekaran K., et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23:685–713. doi: 10.1016/j.echo.2010.05.010. quiz 786-8. [DOI] [PubMed] [Google Scholar]
- 9.Mu G., Li F., Chen X., Zhao B., Li G., Fu H. A visualized pulmonary arterial thrombus by using a modified echocardiographic view in an intermediate-risk acute pulmonary embolism patient: a case report. Clin Case Rep. 2022;10 doi: 10.1002/ccr3.6105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Pruszczyk P., Torbicki A., Kuch-Wocial A., Szulc M., Pacho R. Diagnostic value of transoesophageal echocardiography in suspected haemodynamically significant pulmonary embolism. Heart. 2001;85:628–634. doi: 10.1136/heart.85.6.628. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Fields J.M., Davis J., Girson L., Au A., Potts J., Morgan C.J., et al. Transthoracic echocardiography for diagnosing pulmonary embolism: a systematic review and meta-analysis. J Am Soc Echocardiogr. 2017;30:714–723.e4. doi: 10.1016/j.echo.2017.03.004. [DOI] [PubMed] [Google Scholar]
- 12.Nasser M.F., Jabri A., Limaye S., Sharma S., Hamade H., Mhanna M., et al. Echocardiographic evaluation of pulmonary embolism: a review. J Am Soc Echocardiogr. 2023;36:906–912. doi: 10.1016/j.echo.2023.05.006. [DOI] [PubMed] [Google Scholar]
- 13.Yuriditsky E., Mitchell O.J., Sibley R.A., Xia Y., Sista A.K., Zhong J., et al. Low left ventricular outflow tract velocity time integral is associated with poor outcomes in acute pulmonary embolism. Vasc Med. 2020;25:133–140. doi: 10.1177/1358863X19880268. [DOI] [PubMed] [Google Scholar]
- 14.Isath A., Shah R., Bandyopadhyay D., Bali A., Kanwal A., Spevack D., et al. Dispelling the saddle pulmonary embolism myth (from a comparison of saddle versus non-saddle pulmonary embolism) Am J Cardiol. 2023;201:341–348. doi: 10.1016/j.amjcard.2023.06.048. [DOI] [PubMed] [Google Scholar]
- 15.Alkinj B., Pannu B.S., Apala D.R., Kotecha A., Kashyap R., Iyer V.N. Saddle vs nonsaddle pulmonary embolism: clinical presentation, hemodynamics, management, and outcomes. Mayo Clin Proc. 2017;92:1511–1518. doi: 10.1016/j.mayocp.2017.07.014. [DOI] [PubMed] [Google Scholar]
- 16.Yuriditsky E., Horowitz J.M. The role of the PERT in the management and therapeutic decision-making in pulmonary embolism. Eur Heart J Acute Cardiovasc Care. 2022;11:693–694. doi: 10.1093/ehjacc/zuac102. [DOI] [PubMed] [Google Scholar]
- 17.Burton J.R., Madhavan M.V., Finn M., Ingrassia J.J., Bikdeli B., Nabavi Nouri S., et al. Advanced therapies for acute pulmonary embolism: a focus on catheter-based therapies and future directions. Structural Heart. 2021;5:103–119. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.